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Embryonic stem cell (ESC) self-renewal efficiency is
determined by the level of Nanog expression.
However, themechanisms bywhich Nanog functions
remain unclear, and in particular, direct Nanog target
genes are uncharacterized.Herewe investigateESCs
expressing different Nanog levels andNanog/ cells
with distinct functionally inducible Nanog proteins
to identify Nanog-responsive genes. Surprisingly,
these constitute aminor fraction of genes that Nanog
binds. Prominent among Nanog-reponsive genes is
Estrogen-related receptor b (Esrrb). Nanog binds
directly to Esrrb, enhances binding of RNAPolII,
and stimulates Esrrb transcription. Overexpression
of Esrrb in ESCs maintains cytokine-independent
self-renewal and pluripotency. Remarkably, this acti-
vity is retained in Nanog/ ESCs. Moreover, Esrrb
can reprogram Nanog/ EpiSCs and can rescue
stalled reprogramming in Nanog/ pre-iPSCs.
Finally, Esrrb deletion abolishes the defining ability
of Nanog to confer LIF-independent ESC self-
renewal. These findings are consistent with the func-
tional placement of Esrrb downstream of Nanog.
INTRODUCTION
Self-renewal of mouse embryonic stem cells (ESCs) is under the
intrinsic control of a gene regulatory network centered on the
transcription factors Oct4, Sox2, and Nanog (Chen et al., 2008;
Kim et al., 2008; Loh et al., 2006) (reviewed in Chambers and
Tomlinson, 2009; Jaenisch and Young, 2008). Since its identifi-
cation (Chambers et al., 2003; Mitsui et al., 2003), Nanog has
been considered a central player in the specification of pluripo-
tent cell identity in vivo (Mitsui et al., 2003; Silva et al., 2009)
and in the control of efficient self-renewal of pluripotent cells
in vitro (Boyer et al., 2005; Chambers et al., 2003, 2007; Ivanova
et al., 2006; Loh et al., 2006). As well as the defining functional
feature of conferring cytokine-independent self-renewal when
overexpressed (Chambers et al., 2003), Nanog is able to
increase reprogramming efficiency in cell hybrid experiments
(Silva et al., 2006) and is required for somatic cells to be reprog-
rammed to naive pluripotency (Silva et al., 2009).CeIndividual ESCs fluctuate between states of high Nanog
expression, associated with high self-renewal efficiency, and
low Nanog expression, associated with an increased propensity
to differentiate (Chambers et al., 2007). These functional differ-
ences are likely to be determined by the differential expression
of Nanog target genes. Therefore, it is of particular importance
to identify such target genes and to determine their biological
contribution to Nanog function. With this aim we used comple-
mentary transcriptional profiling strategies to identify potential
targets of Nanog. One of the most prominent genes identified
in this analysis is Esrrb, an orphan nuclear receptor that is
part of the pluripotency gene regulatory network (Chen et al.,
2008; Ivanova et al., 2006; Kim et al., 2008; Loh et al., 2006;
van den Berg et al., 2008, 2010; Wang et al., 2006; Zhang
et al., 2008). Esrrb is involved in ESC self-renewal (Ivanova
et al., 2006; Loh et al., 2006) and has been shown to promote
reprogramming of mouse embryonic fibroblasts (Feng et al.,
2009). However, the regulation of Esrrb in ESCs and the details
of Esrrb function in sustaining pluripotency and promoting
reprogramming are not well understood. We therefore investi-
gated the regulation of Esrrb and the role of Esrrb in ESC self-
renewal and cellular reprogramming using wild-type, Nanog
mutant, and Esrrb mutant cells. Our results highlight the impor-
tant functional interactions between Esrrb and its upstream
regulator Nanog in the context of ESC self-renewal and
pluripotency.RESULTS
The Transcriptional Network Downstream of Nanog
To identify genes controlled by Nanog, we compared the tran-
scriptional profiles of ESCs in which GFP has been knocked in
to one of the Nanog alleles (TNG cells; Chambers et al., 2007)
that were sorted into SSEA1+/GFPhigh and SSEA1+/GFPlow pop-
ulations, together with Nanog+/+ and Nanog/ cells (Chambers
et al., 2007) (Figure 1A). Good agreement between duplicate
samples of Nanog/ RNA indicated reliable output from the
Deep-SAGE protocols. Moreover, broad agreement was
observed between both Nanog/ and Nanog:GFP as well as
betweenNanog+/+ andNanog:GFP+ cells. Of 500 genes showing
the greatest change in expression, Esrrb was the transcription
factor that showed the closest positive correlations with
Nanog and consistent variations in both Nanog:GFP+ versus
Nanog:GFP and wild-type versus Nanog/ comparisons
(fold change R1.5), closely followed by Klf4 (Table S1.1). Toll Stem Cell 11, 477–490, October 5, 2012 ª2012 Elsevier Inc. 477
Figure 1. Identification of Nanog Target
Genes Including Esrrb
(A) Deep-SAGE profile of sorted Nanog-positive
(GFP+) and Nanog-negative (GFP–) TNG cells,
ESCs with wild-type levels of Nanog expression
(RCN(t)) and Nanog/ ESCs (RCNbH(t)). Genes
were ranked according to the expression level and
fold difference in expression in TNG+ versus
TNG and RCN(t) versus RCNbH(t); the plot
shows the first 250 most upregulated (top) or
downregulated (bottom) genes. Colors: yellow,
expression above average; blue, below average.
(B) Esrrb transcript levels in two cell lines over-
expressing Nanog (EF4 and RCN), two cell lines
with wild-type Nanog (E14Tg2a and RCN(t)), two
Nanog+/ cell lines (TbC44 and RCNb(t)), and two
Nanog/ cell lines (TbC44Cre6 and RCNbH(t)).
Error bars: standard deviation (n = 4).
(C) Immunoblot analysis of Esrrb and Nanog levels
in the same ESC lines.
(D) Immunohistochemical analysis of the intracel-
lular localization of Nanog in ESDN-NERT cells
in response to 1 mM tamoxifen as indicated.
(E) Global transcriptional changes after ESDN-
NERT stimulation with tamoxifen as indicated; the
Esrrb changes are in red. Mean expression levels
in three independent experiments are shown.
(F) Venn diagram showing the intersection of
significantly upregulated or downregulated genes
identified in (E) compared to genes bound by
Nanog according to two independent genome-
wide ChIP studies.
(G) Esrrb pre-mRNA kinetics in ESDN-NERT cells
stimulated with tamoxifen as indicated. Error bars:
standard deviation of expression values in three
different clones.
(H) Chromatin from ESDN-NERT cells treated with
1 mM tamoxifen for 0 or 24 hr was immunopre-
cipitated with Nanog or total RNAPolII antibodies.
Enrichment relative to the ArpP0 promoter is
measured using the primers indicated at Esrrb.
Error bars: standard deviation (n = 3); *p % 0.05,
**p% 0.01. See also Figures S1 and S2 and Tables
S1.1 and 1.2.
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further characterized the expression of the Esrrb gene in ESCs
and its regulation by Nanog.
The mouse Esrrb gene has six coding exons, with evidence
for four alternatively spliced Esrrb mRNAs in the ENSEMBL
EST databases (Figure S1A available online). To determine
which of these transcripts are expressed in ESCs, quantitative
PCR (Q-PCR) was used to amplify junctions between the coding
exons and the alternative 50 and 30 untranslated regions (UTRs)
(Figure S1A). In ESCs, the most abundant transcript includes
the 50UTR adjacent to the coding portion of exon 2 and the
30UTR in exon 7 (Figures S1A and S1B).
Different ESC lines in a Nanog mutant series (Chambers et al.,
2003, 2007) showed a correlation between Nanog expression
and levels of Esrrb mRNA (Figure 1B) and protein (Figure 1C).478 Cell Stem Cell 11, 477–490, October 5, 2012 ª2012 Elsevier Inc.These variations in Esrrb mRNA levels reflect transcriptional
control of Esrrb by Nanog rather than RNA stabilization, since
differences in mRNA level (Figure S1C) were also seen for the
pre-mRNA (Figure S1D). Furthermore, tamoxifen-induced elimi-
nation of Nanog from ESCs (Chambers et al., 2007) results in
decreased Esrrb mRNA expression, an effect not attributable
to differentiation as shown by stable Oct4 levels (Figure S1E).
To investigate the dynamics of Nanog control of Esrrb transcrip-
tion, we measured Esrrb mRNA levels in TbC44Cre6 Nanog/
ESCs expressing a tamoxifen-regulatable Nanog-ERT2 fusion
protein (ESDN-NERT, Figure S2A). In these cells Nanog nuclear
relocalization is induced within 15 min of tamoxifen addition
(Figure 1D). Three independent ESDN-NERT lines induced
Esrrb mRNA and protein at levels that correlated to the level
of Nanog-ERT2 mRNA expression (Figures S1F and S1G).
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renewal in the absence of LIF to an extent comparable to that
induced by wild-type Nanog expression (Figure S1I) in an iden-
tical Nanog/ background (Figures 2F and S2A), indicating
that Nanog-ERT2 is fully functional.
To investigate the dynamics of Nanog control of transcription
genome-wide, microarray analyses were performed at 1 hr time
intervals over a 6 hr period following Nanog nuclear relocalization
in ESDN-NERT c3 cells. Sixty-four genes showed a differential
gene expression pattern (R1.5-fold change, p % 0.05) during
the time course (Figure 1E; Table S1.2). This is of interest given
that thousands of binding sites for Nanog have been identified
in genome-wide ChIP studies (Chen et al., 2008; Kim et al.,
2008; Marson et al., 2008). We therefore compared the overlap
between the Nanog-sensitive genes identified in our analysis
with the common Nanog-bound targets identified in ChIP-Seq
studies using our recently generated, publically available Gene-
Prof software (Halbritter et al., 2012). The vast majority of the
Nanog-sensitive genes that we identified were present in both
ChIP-Seq studies (Chen et al., 2008; Marson et al., 2008), but
99% of the genes identified as putative Nanog targets by ChIP
are insensitive to changes in Nanog over the time course of our
study (Figure 1F).
Microarray analyses were also performed following induction
of wild-type Nanog in Nanog/ ESDN-iNanog ESCs (which
carry a doxycycline-inducible Nanog transgene; Figure 2F).
Since full transcript induction in ESDN-iNanog cells is achieved
by 6 hr (Figure S2B), microarray analysis used cells induced for
0, 6, or 12 hr. In this system, only 31 genes showed R1.5-fold
change in expression after 12 hr of induction (p % 0.05)
(Figure S2C and Table S1.3). The lower number of identified
genes is likely to result from the slower induction of nuclear
Nanog in ESDN-iNanog compared to ESDN-NERT cells. The
vast majority of targets (21/31) were also identified in ESDN-
NERT cells and 8/10 of the remaining genes are also differen-
tially expressed in ESDN-NERT cells but with <1.5-fold change.
Together these analyses identify a reliable list of Nanog-respon-
sive genes with which to explore the mechanisms of Nanog
activity in ESCs.
Strikingly, Esrrb is the transcript showing the most
pronounced induction in the ESDN-NERT microarray (Figure 1E;
Table S1.2) and the strongest induced transcription factor in
ESDN-iNanog cells (Figure S2E; Table S1.3). Of the other 63
targets identified in ESDN-NERT cells, 10 are transcription
factors expressed at significant levels. Of these, the closest
transcription factor to change after Esrrb in both ESDN-NERT
and ESDN-iNanog cells is Klf4, the only other transcription
factor to show a consistent positive change (R1.5-fold) in all
other data sets (Table S1).
Q-PCR confirmed the rapid induction of Esrrb mRNA by
Nanog-ERT2 (Figure S1H) and detected increased Esrrb pre-
mRNA within 20 min of tamoxifen treatment (Figure 1G), arguing
in favor of a direct role for Nanog in Esrrb transcription.
Moreover, tamoxifen treatment of ESDN-NERT cells not only
stimulated binding of Nanog-ERT2 to Esrrb (Figure 1H) but
also resulted in a 2-fold increase in RNAPolII recruitment to the
Esrrb promoter (Figure 1H). These results establish Esrrb as
a major positive target of direct transcriptional activation by
Nanog in ESCs.CeEsrrb Overexpression Confers Cytokine-Independent
Self-Renewal in the Absence of Nanog
The observation that Nanog lies upstream of Esrrb prompted us
to investigate whether the cytokine independence conferred
upon ESCs by Nanog overexpression (Chambers et al., 2003)
might be mediated by Esrrb. Supertransfection of lifr/ cells
(Chambers et al., 2003) with an episomal Esrrb expression vector
resulted in self-renewal in the absence of IL6/sIL6R (Figure 2A).
Integration of a loxP-flanked Esrrb transgene (Figure 2B) allowed
the isolation of cell lines that overexpress Esrrb reversibly
(EfEsrrb cells) (Figure S3A). These cells showed a constitutive
capacity to form undifferentiated alkaline phosphatase (AP)-
positive self-renewing colonies in the presence of the LIF
antagonist hLIF-05 (Vernallis et al., 1997) (Figures 2C and 2D),
a phenotype reversed by Cre expression (Figures 2C and 2D).
To rigorously determine whether Esrrb overexpression is suffi-
cient to maintain pluripotency through clonal expansion in the
absence of LIF signaling, EfEsrrb cells were plated at clonal
density in the presence of LIF antagonist and passaged twice
at clonal density. At this point, control parental cells had
completely differentiated and could not be passaged further. In
contrast, EfEsrrb clones continued to self-renew. These cells
were treated with Cre, and GFP-expressing cells that had
deleted the Esrrb ORF (Figure 2B) were expanded in LIF. Injec-
tion of these cells into C57BL/6 blastocysts gave rise to adult
chimeras (Figure 2E). Therefore, Esrrb is able to functionally
substitute for Nanog overexpression to sustain gp130-indepen-
dent self-renewal.
A more precise comparison of self-renewal induced by over-
expression of Nanog, Esrrb, and Klf4 (the second transcription
factor showing closest correlation with Nanog in our analysis)
was obtained using recombinase-mediated cassette exchange
(RMCE) to introduce doxycycline-inducible transgenes into the
same locus of E14Tg2a cells (Figure S3B; details in Experimental
Procedures). Cells were plated at clonal density with or without
LIF, in increasing doxycycline concentrations. Maximal self-
renewal efficiency was observed at 3 mg/ml doxycycline for
Nanog and Klf4, but at 1 mg/ml for Esrrb, with excessive Esrrb
expression stimulating differentiation (Figures S3C and S3D).
These results indicate that the self-renewal phenotypes directed
by overexpression of Esrrb and Nanog were comparable with
both surpassing Klf4.
The ability of Esrrb to direct cytokine-free self-renewal inde-
pendent of Nanog expression was next tested. Clonal deriva-
tives of the Nanog/ line TbC44Cre6 were obtained that had
integrated a constitutively expressed Esrrb transgene (Figures
S3E and S3F). These cell lines form undifferentiated colonies
when plated without LIF at clonal density (Figures S3G and
S3H). Addition of LIF to Esrrb-overexpressing cells increased
clonal self-renewal efficiency. Therefore, Esrrb acts coopera-
tively with LIF but can act independently of Nanog.
To more precisely compare self-renewal induced by Esrrb or
Nanog overexpression in Nanog/ cells, RCME was used to
introduce doxycycline-inducible Nanog or Esrrb transgenes
into the same locus in TbC44Cre6 cells (ESDN-iNanog and
ESDN-iEsrrb cells; Figure 2F). This resulted in comparable levels
of Nanog and Esrrb mRNAs following doxycycline treatment
(Figure S4A). These cells were plated at clonal density in
ESC medium supplemented with LIF or LIF antagonist, in thell Stem Cell 11, 477–490, October 5, 2012 ª2012 Elsevier Inc. 479
Figure 2. Esrrb Overexpression Confers LIF and Nanog-Independent Self-Renewal
(A) lifr/:PyLT+ LRK1 cells were transfected with episomal plasmids encoding the indicated ORF (EV; empty vector) and the number of AP-positive colonies was
determined after clonal density plating in the absence of IL-6/sIL6R. Error bars: standard deviation (n = 3).
(B) Schematic representation of EfEsrrb ESCs.
(C) Colony morphology (top) and AP staining (bottom) of EfEsrrb c1 cultured in the presence of hLIF-05.
(D) E14Tg2a, Nanog-, and Esrrb-overexpressing cells before and after Cre reversion were plated at clonal density and cultured in the presence or absence of LIF
or hLIF-05 for 7 days, and the number of AP-positive colonies was counted. Error bars: standard deviation (n = 3).
(E) Chimeras generated after injection into C57BL/6 blastocysts of EfEsrrb-Cre ESCs passaged twice at clonal density in the presence of hLIF-05 and transfected
with a Cre expression vector to excise the Esrrb transgene.
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Esrrb Functions Downstream of Nanog in ESCspresence or absence of doxycycline. Induction of Esrrb or Nanog
resulted in the formation of undifferentiated AP-positive colonies
in the complete absence of LIF signaling (Figure 2G). Interest-
ingly, a 5-fold greater self-renewal efficiency was seen when
Nanog rather than Esrrb was induced from the same locus (Fig-
ure 2H). These results show that while Esrrb can act indepen-
dently of Nanog, restoring Nanog expression in Nanog/
ESCs has a greater effect on self-renewal efficiency.
Nanog overexpression affects the ability of ESCs to differen-
tiate in vitro (Chambers et al., 2003). To determine whether Esrrb
overexpression has a similar phenotype, ESDN-iNanog and
ESDN-iEsrrb lines were cultured in N2B27. Overt neural differen-
tiation was observed for ESDN-iNanog and ESDN-iEsrrb cells in
the absence of transgene induction. In contrast, doxycycline
treatment of ESDN-iNanog or ESDN-iEsrrb cultures blocked
neural differentiation (Figure 2I).
Doxycycline-treated ESDN-iNanog and ESDN-iEsrrb cells
could be passaged in the presence of LIF antagonist for more
than 1 month (Figure S4B) and retained the ability to form terato-
carcinomas composed of representative tissues of all three
primary germ layers as well as undifferentiated embryonal carci-
noma (EC) upon transplantation to mice (Figure S4C; Table S2).
Therefore, Esrrb is able to maintain ESC pluripotency through
multiple passages without gp130 signaling and even in the
absence of Nanog.
Esrrb Reverts EpiSCs to Chimera-Competent
Pluripotency
It has been shown that Nanog or Klf4 overexpression can
reprogram EpiSCs to ESC pluripotency (Guo et al., 2009; Silva
et al., 2009). Therefore, the abilities of Nanog, Esrrb, and Klf4
to mediate the reversion of EpiSCs to an ESC state were
compared. Episomal expression of Nanog, Esrrb, or Klf4,
coupled with removal of Activin/Fgf, could induce reversion of
EpiSCs to an ESC-like state (Figure 3A). Esrrb displayed a higher
reprogramming efficiency than Nanog or Klf4 (Figure 3A).
Furthermore, Nanog and Esrrb allowed AP-positive colony
formation in all conditions (Figure 3A), whereas Klf4 could only
revert EpiSCs to ESC pluripotency when combined with LIF/2i
(Figure 3A). Primary Epi-iPSC colonies displayed an undifferen-
tiated morphology (Figure 3B) and in FCS/LIF/GMEMb, Nanog
and Esrrb, but not Klf4, induced the re-expression ofNanog:GFP
(Figure 3C) and Pecam1 (Figure 3D), a cell surface marker ex-
pressed in the inner cell mass (ICM)/ESCs and downregulated
in the epiblast/EpiSCs (Hayashi et al., 2008; Robson et al.,
2001). To further characterize the Esrrb-induced Epi-iPSCs,
clones were picked and expanded in FCS/LIF/GMEMb. Expres-
sion of Nanog, Sox2, Klf4, Klf2, and Tbx3 were restored to ESC
levels, while expression of the early marker of differention Fgf5
was reduced (Figure 3E). Injections of the Esrrb-reverted Epi-(F) Schematic representation of the genetic manipulations used to make ESDN-i
(G) Colonymorphology of ESDN-iNanog (iN) or ESDN-iEsrrb (iE) cells plated at clo
Right hand panels: AP staining of colonies formed in the presence of doxycyclin
(H) Number of AP-positive colonies formed after clonal density plating of ESDN-iN
(+/ doxycycline) for 8 days. Error bars: standard deviation (n = 3).
(I) ESDN-iNanog (iN) and ESDN-iEsrrb (iE) cells in a neural differentiation protoco
fixed, stained for bIII-Tubulin (Tuj), and analyzed by fluorescence microscopy.
See also Figures S3 and S4 and Table S2.
CeiPSCs into blastocysts produced adult chimeras, indicating
that enforced Esrrb expression can restore chimera-forming
potential to EpiSCs (Figure 3F; Table S3).
To investigate the reproducibility of these findings, plasmids
containing loxP-flanked Nanog, Esrrb, or Klf4 ORFs upstream
of GFP (Figure S5A) were integrated into RC EpiSCs that
constitutively express tamoxifen-inducible Cre recombinase
(Cre-ERT2) from ROSA26 (RC = RosaCre). Overexpression
of Nanog, Esrrb, or Klf4 was verified by Q-PCR (Figure S5B).
Populations were then switched to 2i/LIF/N2B27. ESC-like
colonies were obtained, with Esrrb displaying a 5-fold higher
reprogramming efficiency than Nanog or Klf4 (Figure S5C).
Esrrb-induced Epi-iPSC clones were treated with tamoxifen
and transgene deletion was monitored by GFP expression (Fig-
ure S5D). Pecam1 re-expression in Esrrb-induced Epi-iPSCs
was maintained following transgene excision, suggesting stable
reprogramming to an ESC state (Figure S5E). Following Cre exci-
sion of Esrrb, cells became dependent on LIF for colony forma-
tion and displayed heterogenous expression of Nanog, Esrrb,
and Klf4 (Figures S5F and S5G). These results show that Esrrb
expression reinstates ESC pluripotency in EpiSCs.
Esrrb Can Reprogram Nanog–/– EpiSCs to Chimera
Competency
Nanog is dispensable for the establishment and maintenance of
primed pluripotency (Osorno et al., 2012) but is required for the
acquisition of naive pluripotency, since somatic Nanog/ cells
cannot be converted into fully reprogrammed iPSCs (Silva
et al., 2009). To determine whether Esrrb could revert EpiSCs
to an ESC state in the absence of Nanog, ESDN-iNanog and
ESDN-iEsrrb ESCs were converted into EpiSC lines (EpiDN-iNa-
nog and EpiDN-iEsrrb) by passaging in Activin/FGF (Guo et al.,
2009). This allowed comparative investigation of the abilities of
Nanog and Esrrb to impose an ESC identity by simply applying
doxycycline and removing Activin/Fgf. AP-positive Epi-iPSC
colonies were obtained following induction of Nanog and, to
our surprise, also following Esrrb induction (Figure 4A). However,
whereas Esrrb induced EpiSC reprogramming with greater effi-
ciency than Nanog in wild-type cells, the opposite was observed
in Nanog/ cells (Figures 4A and 4B), suggesting that Nanog is
required for maximal Esrrb efficacy. AP-positive colonies were
obtained after as little as 24 hr exposure to doxycycline of both
EpiDN-iNanog and ESDN-iEsrrb cells with a clear correlation
between the doxycycline treatment period and the number of
Epi-iPSC colonies obtained (Figures 4A and 4B). Esrrb-induced
Epi-iPSDN-iEsrrb clones were picked and expanded in the
absence of further transgene induction and had reacquired
expression of Sox2, Klf2, and Tbx3 and downregulated Fgf5
(Figure 4C). Importantly, Epi-iPSDN-iEsrrb cells reacquired
both ESC morphology and levels of Nanog:GFP similar to thoseNanog or ESDN-iEsrrb cells.
nal density and cultured in the presence of hLIF-05 (+/ doxycycline) for 8 days.
e.
anog (iN) or ESDN-iEsrrb (iE) cells in the presence of LIF or hLIF-05 and cultured
l, without (top rows) or with (bottom rows) doxycycline for 9 days. Cells were
ll Stem Cell 11, 477–490, October 5, 2012 ª2012 Elsevier Inc. 481
Figure 3. Expression of Esrrb Reverts
EpiSCs to Chimera Competency
(A) AP-positive colony formation by Epi-iPSCs.
EpiSCs expressing polyoma large T-antigen were
transfected with episomal vectors encoding
empty vector (EV), Nanog, Klf4, or Esrrb, plated in
the indicated medium containing puromycin, and
stained for AP after 7 days. Error bars: standard
deviation (n = 3).
(B) Morphology of primary Epi-iPSC colonies
formed after transfection of the respective
episomal vector and culture in the indicated
medium for 7 days.
(C) Morphology and Nanog:GFP expression of
primary Epi-iPSC colonies formed after trans-
fection of the respective episomal vector and
culture in FCS/LIF/GMEMb for 7 days.
(D) FACS analysis of Pecam1 expression 7 days
after transfection of the indicated DNAs. TNG/T
ESCs (blue) and EpiSCs (gray) were used as
controls for Pecam1 expression.
(E) mRNA expression in E14/T EpiSC and Epi-
iPSC colonies expanded in the absence of selec-
tion after episomal expression of Esrrb and
medium switch into FCS/LIF/GMEMb. Error bars:
standard deviation of gene expression in three
independent experiments.
(F) Chimeric mouse obtained from blastocyst
injection of Esrrb-induced Epi-iPSCs.
See also Figure S5 and Table S3.
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renewing AP-positive colonies in BMP/LIF and 2i/LIF (Figure 4E).
Consistent with these findings, Epi-iPSDN-iEsrrb cells injected
into blastocysts produced adult chimeras (Figure 4F; Table
S3). These results demonstrate that Esrrb can functionally
substitute for the hitherto unique capacity of Nanog to reprogram
Nanog/ cells to naive pluripotency.
Esrrb Can Reprogram Nanog–/– Neural Stem Cells
Reprogramming of neural stem cells (NSCs) has previously been
reported to depend on Nanog (Silva et al., 2009). To ascertain if
Esrrb overexpression could also promote reprogramming of
NSCs, the efficiency of formation of hybrid colonies capable of
being propagated in ESC medium (Silva et al., 2006) was
compared following fusion of E14/T NSCs with wild-type ESCs
or ESCs overexpressing Esrrb (Figure 2B) or Nanog. Overex-
pression of Esrrb stimulated formation of pluripotent hybrid
colonies with a similar efficiency as that observed with Nanog
overexpression (Figures S6A and S6B).
To determine whether the reprogramming capacity of Esrrb
required the presence of Nanog in either fusion partner, we482 Cell Stem Cell 11, 477–490, October 5, 2012 ª2012 Elsevier Inc.developed an experimental system in
which Nanog/ NSCs are fused to
Nanog/ ESCs overexpressing Esrrb.
NSCs derived from Nanog/ RCNbH(t)
can be propagated in NSC medium con-
taining FGF/EGF (Conti et al., 2005) and
show the characteristic vimentin-positive
NSC morphology (Figure S6C). These
Nanog/ NSCs were fused to ESDN-
CAGE (Figure S6D) and plated in ESC medium in the presence
of puromycin and hygromycin to select for hybrids that reacti-
vated Nanog transcription from the NSC genome. Control cell
fusions of RCNbH(t) NSCs to Nanog and Esrrb overexpressing
Nanog+/+ ESCs gave rise to 100–500morphologically undifferen-
tiated hybrid colonies per 106 cells fused (Figure S6E; Table S4).
However, no undifferentiated colonies were observed after
fusion of RCNbH(t) NSCs with TbC44Cre6 ESCs. In contrast,
fusions between ESDN-CAGE ESCs and RCNbH(t) NSCs
produced undifferentiated hybrid colonies that could be main-
tained in standard ESC medium through multiple passages
(Figure S6E; Table S4).
To examine whether stable reprogramming of the NSC
genome could be achieved without continued transgene ex-
pression, fusion experiments were performed using ESDN-
iNanog and ESDN-iEsrrb cells. Nanog/ RCNbH(t) NSCs were
transfected with a CAG-driven TdTomato-IRES-hygromycinR
construct. RCNbH(t) Red NSCs were fused with ESDN-iNanog
or ESDN-iEsrrb cells (Figure 5A) and primary hybrids were re-
plated in blasticidin and hygromycin. In the absence of doxycy-
cline, only a small number of hybrid colonies were obtained
Figure 4. Nanog Null EpiSC Are Reverted to Naive Pluripotency by Esrrb Expression
(A) Nanog/ EpiSCs carrying doxycycline-inducible Nanog or Esrrb transgenes were plated in FCS/LIF/GMEMb with doxycycline for the indicated times. After
7 days, plates were stained for AP.
(B) Scoring of the AP colonies obtained from the experiment described in (A). Error bars: standard deviation (n = 3).
(C) mRNA expression in uninduced EpiDN-iEsrrb and the reverted Epi-iPSDN-iEsrrb ESC-like colonies obtained by induction of Esrrb and expansion in the
absence of selection and doxycycline. Error bars: standard deviation of gene expression in two independent experiments.
(D) Brightfield (top panels) and fluorescence (bottom panels) images of ESDN-iEsrrb, EpiDN-iEsrrb, and Epi-iPSDN-iEsrrb cells.
(E) AP-positive colonies of Epi-iPSDN-iEsrrb cells grown in N2B27 supplemented with BMP/LIF (top) or 2i/LIF (bottom).
(F) Chimeric mouse obtained from a blastocyst injection with Epi-iPSDN-iEsrrb cells.
See also Table S3.
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and could not be expanded. In contrast, Nanog and Esrrb
induction resulted in the formation of self-renewing AP-positive
colonies (Figures 5B and S6G). Nanog induction promoted
reprogramming at high frequency (300 colonies/million
NSCs fused) as previously reported (Silva et al., 2006, 2009).
In contrast, Esrrb overexpression resulted in a 10-fold lower
reprogramming efficiency (Table S5). These differences were
not due to altered fusion efficiencies, since similar results were
obtained after replating sorted primary hybrids (Figure S6F;
Table S6). Nonetheless, all reprogrammed hybrid lines could
be expanded and cultured over multiple passages. Cells were
then maintained or released from doxycycline and passaged in
the presence or absence of G418 (to select for transcription
from Nanog; Figure 5A). Hybrid lines could be serially passaged
without continued Esrrb or Nanog in G418 (Figure 5C). In the
absence of G418 selection, hybrid cells could be propagated
without continued Esrrb or Nanog induction but had anCeincreased tendency to differentiate, similar to Nanog/ ESCs
(Chambers et al., 2007). This propensity was eliminated upon
induction of Esrrb, identifying a further common feature between
Esrrb and Nanog.
The stability of reprogramming of RCNbH(t) NSCs was inves-
tigated by analyzing gene expression in hybrid lines cultured in
the presence or absence of doxycycline or G418 (Figure 5D).
NSC-specific genes were silenced during reprogramming and
were not re-expressed after transgene repression, while endog-
enous pluripotency genes were expressed in all lines analyzed
even after withdrawal of doxycycline. Release of ESDN-iEsrrb 3
RCNbH(t) hybrid lines from doxycycline and G418 resulted in an
increased tendency to differentiate into primitive endoderm, as
judged by morphology and GATA6 expression (Figures 5C and
5D). Despite this, culture in 2i/LIF/N2B27, a condition permissive
only for completely undifferentiated cells, resulted in colonies
with an undifferentiated morphology that could be serially
passaged (Figure S6H). These data show that NSCs can bell Stem Cell 11, 477–490, October 5, 2012 ª2012 Elsevier Inc. 483
Figure 5. In Vitro Reprogramming by Cell Fusion Can Proceed in the Absence of Nanog
(A) Schematic representation of the genetic manipulations performed on the lines used in the fusion experiments: ESDN-iNanog and ESDN-Esrrb cells and
RCNbH(t) Red NSCs.
(B) Colonies formed by ESDN-iNanog (iN) or ESDN-iEsrrb (iE)3 RCNbH(t) Red NSCs hybrids after 16 days selection in blasticidin/hygromycin in the presence or
absence of doxycycline.
(C) Morphology of ESDN-iEsrrb (iE) 3 RCNbH(t) Red NSC hybrids cultured in doxycycline or released from doxycycline for three passages (10 days) in the
presence or absence of G418 to select for active Nanog transcription.
(D) Gene expression profiles of endogenous genes in RCNbH(t) Red NSCs, ESDN-iNanog (iN) cells or ESDN-iEsrrb (iE) cells, and hybrid lines after three passages
in the indicated conditions. Primers do not detect transgenes. Nanog primers bind to intron I, which is not deleted in the targeted alleles. Transcript levels are
normalized to TBP and relative to expression in RCNbH(t) Red NS (Olig2) or ESDN-iNanog cells cultured in G418 (all other genes). Error bars: ESC3NSC hybrids:
standard deviation of gene expression in three independent clones. ESC and NSC lines: standard deviation of gene expression in two independent experiments.
See also Figure S6 and Tables S4, S5, and S6.
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overexpression of Esrrb and that Esrrb is required to stabilize
the reprogrammed hybrids but is dispensable once pluripotency
is attained.484 Cell Stem Cell 11, 477–490, October 5, 2012 ª2012 Elsevier Inc.Esrrb Can Complete Reprogramming of Nanog–/–
Somatic Cells to Naive Pluripotency
The ability of Esrrb to substitute for Nanog during transcription-
factor-based induced pluripotency (Takahashi and Yamanaka,
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of this process with Nanog/ cells stalling in an intermediate,
pre-iPSC state in which they acquire themorphology and growth
factor dependence of ESCs but do not express endogenous
pluripotency genes or silence retroviral transgene expression
(Silva et al., 2009). NSCs were generated from ESDN-iNanog
and ESDN-iEsrrb ESCs and passaged ten times in NSCmedium.
These lines express the NSC marker Olig2 and Sox2 but not
other pluripotency factors (Figure 6D). NSDN-iNanog and
NSDN-iEsrrb cells were infected with retroviral vectors encoding
Oct4, Klf4, c-Myc, and dsRed (to monitor LTR silencing upon
completion of reprogramming; Figure 6A). Colonies resembling
pre-iPSCs emerged at day 5 postinfection and could be main-
tained on feeders without reactivating Nanog:GFP (Figure 6B).
Other pluripotency genes remained silenced and viral trans-
genes were expressed (Figures 6D and 6E). pre-iPSDN-iNanog
and pre-iPSDN-iEsrrb cells were then treated with doxycycline
to activate the Nanog or Esrrb transgenes. This was performed
with or without 5-azacytidine, which has been shown to promote
reprogramming (Huangfu et al., 2008) and facilitate the pre-iPSC
to iPSC transition (Theunissen et al., 2011). Nanog induction in
pre-iPSDN-iNanog cells led to the emergence of Nanog:GFP+
cells by day 6 (Figure 6C). Strikingly, Esrrb induction resulted in
faster, more pronounced reactivation of Nanog:GFP. For both
pre-iPSDN-iNanog and pre-iPSDN-iEsrrb, G418-resistant,
Nanog:GFP+ colonies could be picked and expanded without
feeders or doxycycline. The resulting iPSDN-iNanog and
iPSDN-iEsrrb lines resembled the parental ESC linesmorpholog-
ically, were Nanog:GFP+/dsRed– (Figure 6F), expressed endog-
enous pluripotency genes, and had silenced the viral transgenes
(Figures 6D and 6E). Blastocyst injection of iPSDN-iEsrrb cells
resulted in contribution to midgestation embryos (Figure 6G;
Table S7). These results demonstrate that Esrrb can drive
completion of reprogramming in the absence of Nanog, indi-
cating that Esrrb can substitute for Nanog in the acquisition of
pluripotency.
Esrrb and Nanog Share Target Genes
The results presented so far argue in favor of the existence of
a degree of functional overlap between Esrrb and Nanog activity
in pluripotent cells. Therefore, a comparison of the transcrip-
tional programs activated in response to Nanog and Esrrb
induction was performed by microarray analysis of doxycy-
cline-treated ESDN-iNanog and ESDN-iEsrrb cells. An overall
similar transcriptional response was detected upon Esrrb or
Nanog elevation (Figure S2D) with 20%of the top 50 upregulated
genes common between ESDN-iNanog and ESDN-iEsrrb cells
(Figure S2E). The only transcription factor in this group was
Klf4. Interestingly, Nanog induced Klf4 more effectively than
Esrrb (Figure S2F). These results suggest that Esrrb can partially
recapitulate Nanog activity by modulating a common set of
transcriptional targets.
Self-Renewal in Esrrb Knockout Cells
To determine the requirement of Esrrb in ESC self-renewal,
cells homozygous for a conditional Esrrb knockout allele
(Esrrbf/fn) (Chen and Nathans, 2007) and expressing Cre-ERT2
were generated (Figures 7A, S7A, and S7B). Tamoxifen treat-
ment of Esrrbf/fn cells increases the degree of differentiation inCethese cultures. Nonetheless, stable EsrrbD/D cell lines genetically
devoid of Esrrb were readily isolated (Figure S7C and S7D).
Although they show an impaired ability to self-renew in clonal
assays (Figure 7C), EsrrbD/D cells can be propagated in FCS/
LIF/GMEMb and maintain Oct4 expression (Figure 7B). These
results establish the fact that despite having a clear stimulatory
effect on the efficiency of colony formation, Esrrb is formally
dispensable for ESC self-renewal.
Nanog was originally identified on the basis that overexpres-
sion conferred LIF-independent self-renewal (Chambers et al.,
2003). The foregoing results indicate that Esrrb has a significant
self-renewal function. If the hypothesis that Nanog mediates
a significant portion of its self-renewal functions via Esrrb is
correct, then Esrrb knockout should reduce the self-renewal
efficiency conferred by Nanog overexpression. Esrrbf/fn cells
were transfected with a Nanog transgene or a control Esrrb
transgene. Clonal overexpressing lines (Esrrbf/fn+Nanog and
Esrrbf/fn+Esrrb) (Figures S7E and S7F) were treated with tamox-
ifen to induce deletion of Esrrb and stable knockout lines were
derived (Figures S7C and S7D). Six Nanog and six Esrrb overex-
pressing Esrrbf/fn and derivative EsrrbD/D lines were tested for
their ability to self-renew in the presence or absence of LIF
in clonal assays (Figure 7C). Nanog overexpression resulted in
the formation of undifferentiated colonies by Esrrbf/fn ESCs
in the absence of LIF. Enforced Esrrb expression gave com-
parable numbers of undifferentiated colonies in the absence
of LIF (Figure 7C), and this number was unaltered following
deletion of endogenous Esrrb alleles. In contrast, Esrrb deletion
in Esrrbf/fn+Nanog ESCs produced a decrease in self-renewal
efficiency in the presence of LIF (Figure 7C). More impressively,
the defining ability of Nanog to promote LIF independence in
ESCs was completely demolished by loss of Esrrb (Figure 7C).
EsrrbD/D+Nanog ESCs primarily formed differentiated colonies
in the absence of LIF (Figure 7D). These observations establish
that an important component of Nanog function is conferred
by its ability to stimulate Esrrb expression in ESCs.
DISCUSSION
Genome-wide ChIP studies in ESCs have determined that
pluripotency factors bind in proximity to one another at target
genes (Chen et al., 2008; Kim et al., 2008). This suggests that
the expression of these genes is under the combinatorial control
of transcription factors of the pluripotency gene regulatory
network (GRN) (Ptashne and Gann, 2001). However, it is unclear
to what extent changes in the level of a single factor influence
the expression of pluripotency GRN targets (Chambers and
Tomlinson, 2009). Herewe analyzed the effects of altering Nanog
levels upon transcription in ESCs. Using the recently developed
GeneProf software for integrating published data sets (Halbritter
et al., 2012), more than 5,000 genes were confirmed to bind
Nanog in at least two independent studies. Surprisingly,
however, only 64 genes showed a R1.5-fold change in ex-
pression 6 hr (p % 0.05) after reinduction of Nanog activity in
Nanog/ ESCs. This indicates that the presence of Nanog is
not enough for most genes to which Nanog is bound to alter
their transcription rates. This may be due to the binding of
multiple additional pluripotency transcription factors at these
targets, such that loss of Nanog is insufficient to criticallyll Stem Cell 11, 477–490, October 5, 2012 ª2012 Elsevier Inc. 485
Figure 6. Esrrb Can Reprogram Nanog–/– Somatic Cells to Naive Pluripotency
(A) Experimental scheme used to derive pre-iPSCs and to induce completion of reprogramming.
(B) Morphology and Nanog:GFP expression in pre-iPSDN-iEsrrb cells cultured in the absence of doxycycline (top) or in doxycycline/5-azacytidine for 3 days
(bottom).
(C) FACS plots of viral transgene expression (dsRed) and Nanog:GFP in pre-iPSDN-iNanog (iN) or pre-iPSDN-iEsrrb (iE) cells treated with doxycycline/5-aza-
cytidine as indicated. Percentages of cells positive for Nanog:GFP are shown.
(D) Q-PCR of endogenous genes in ESDN-iNanog (iN) or ESDN-iEsrrb (iE) cells and derivative NSCs, pre-iPSCs, and iPSCs. Primers do not detect trans-
genes. Nanog primers bind to intron I, which remains in all targeted cells. All cell lines were maintained without doxycycline for at least three passages.
mRNA levels (normalized to TBP) are relative to expression in NSDN-iEsrrb cells (Olig2) or ESDN-iEsrrb cells (all other genes). Error bars: iPSCs: standard
deviation of gene expression in three independent clones. ESC, pre-iPSC, and NSC lines: standard deviation of gene expression in three independent
experiments.
(E) Q-PCR of retroviral transgenes in ESDN-iNanog (iN) or ESDN-iEsrrb (iE) cells and derivative NSCs, pre-iPSCs, and iPSCs. Primers do not detect endogenous
transcripts. mRNA levels (normalized to TBP) are relative to expression in pre-iPSDN-iEsrrb cells. Error bars: standard deviation of expression values in three
independent experiments.
(F) Morphology, dsRed, and Nanog:GFP expression in iPSDN-iEsrrb cells cultured on gelatin without doxycycline for three passages.
(G) Midgestation embryo obtained from blastocyst injection of iPSDN-iEsrrb cells transfected with a ubiquitously expressed TdTomato transgene (right); control
embryo (left).
See also Table S7.
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Figure 7. Loss of Esrrb Impairs Nanog-Driven LIF Independence
(A) Schematic representation of the genetic manipulations used to make conditional knockout (Esrrbf/fn) ESCs that have two floxed Esrrb alleles and express
Cre-ERT2.
(B) Morphology and expression of Oct4 and Esrrb in Esrrbf/fn and deleted EsrrbD/D lines.
(C) Colony formation after clonal density plating and 7 days culture (+/ LIF; values are the average of six independent clones for each indicated line). Error bars:
standard deviation of the results obtained from six clones each analyzed in triplicate.
(D) Representative morphologies of colonies formed by the indicated lines after 7 days of culture (+/ LIF).
See also Figure S7.
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exerted by the remaining factors. Whether combinatorial control
may also limit the transcriptional response to changes in the
level of other pluripotency transcription factors is a relevant point
for the further understanding of the dynamics and robustness
of the pluripotency GRN. Modulating the Esrrb level also affects
a limited number of genes. Possibly a limited transcriptional
response is a common feature of transcription factors that are
heterogeneously expressed in ESCs. Previous work (Hall et al.,
2009) analyzing the effect of acute Oct4 depletion detected
a much greater number of genes showing prompt transcrip-
tional modulation: 2,714 genes showed a R1.5-fold change in
expression after 5 hr of Oct4 depletion. The radical differencesCeobserved between the modulation of Oct4 and Nanog are sup-
ported by genetic evidence showing that tight control of Oct4
levels is necessary to maintain the pluripotent state (Niwa
et al., 2000), while fluctuations in Nanog confer flexibility to the
network (Chambers et al., 2007).
Among the identified Nanog targets, Esrrb shows the stron-
gest transcriptional induction. Nanog binds directly at the Esrrb
locus, recruits RNAPolII to the Esrrb promoter, and increases
Esrrb pre-mRNA levels within 20 min. Esrrb overexpression
maintains the ability to form adult chimeras during passage of
ESCs at clonal density in the complete absence of gp130
signaling, a function first described for Nanog (Chambers
et al., 2003). Another identified Nanog target is Klf4, which, likell Stem Cell 11, 477–490, October 5, 2012 ª2012 Elsevier Inc. 487
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but without LIF antagonism (Hall et al., 2009; Niwa et al., 2009).
Our findings that Esrrb and Klf4 are direct targets of Nanog,
coupled with the notion that Esrrb can positively regulate
Nanog (van den Berg et al., 2008), identifies Nanog, Esrrb, and
Klf4 as acting to stabilize ESC self-renewal through positive
feedback (Davidson, 2010; Oliveri et al., 2008).
Given the fact that Esrrb can activate Nanog expression
(van den Berg et al., 2008), we excluded the possibility that the
effects of Esrrb overexpression were mediated by Nanog by
showing that the ability of Esrrb to promote LIF independence
is maintained in Nanog/ ESCs. Esrrb shares this ability with
Klf2 (Hall et al., 2009). Klf2 overexpression was suggested to
allow resistance to differentiation of Nanog+/+ cells in serum-
free medium (Hall et al., 2009). Here we report that Esrrb can
also suppress differentiation in serum-free medium; remarkably
it can do so in cells lacking Nanog. These results define Esrrb as
a potent intrinsic mediator of self-renewal in ESCs, an ability
underlined by the capacity of Esrrb to induce LIF independence
to a greater extent than Klf4 and with efficiency comparable with
that of Nanog. Nonetheless, in the absence of LIF, Esrrb-overex-
pressing cells formed colonies that had more differentiated
margins compared to Nanog-overexpressing colonies. More-
over, doxycycline treatment of animals injected with ESDN-
iNanog, but not ESDN-iEsrrb, cells produced teratocarcinomas
that were almost exclusively composed of EC cells (Table S2).
This indicates that Nanog is a stronger suppressor of differenti-
ation than Esrrb, confirming Nanog at the top of the hierarchy
of factors able to sustain the undifferentiated state in ESCs.
The reversion of EpiSCs into an ESC-like pluripotent state
has been reported by overexpression of several transcription
factors including Nanog, Klf4, Klf2, Nr5a, c-Myc, and Stat3
(Guo and Smith, 2010; Guo et al., 2009; Hall et al., 2009; Hanna
et al., 2009; Yang et al., 2010). The overexpression of these
factors alone is, reportedly, not sufficient to reestablish chimera
competency in EpiSCs but must be accompanied by removal of
Activin and Fgf (Hall et al., 2009). In addition, of the tested re-
programming factors, Nanog alone is able to revert EpiSCs to
chimera competency without the need for additional Gsk3/Erk
inhibition (Silva et al., 2009; Theunissen et al., 2011), LIF signaling
(Theunissen et al., 2011; Yang et al., 2010), or fibroblast cocul-
ture (Hanna et al., 2009). Here we show that Esrrb surpasses
Nanog in the efficiency of reprogramming EpiSCs to chimera
competent pluripotency. In fact, Esrrb can mediate this effect
even in the presence of the complex and supposedly deleterious
environment provided by serum and in the absence of LIF. In
contrast, Klf4, another Nanog target gene, was unable to revert
EpiSCs to ESC pluripotency unless exogenous LIF and inhibitors
of Gsk3 and Erk signaling were supplied. These results suggest
that Esrrb and Nanog play similar roles during reprogramming.
To conclusively consolidate this notion we determined that
Esrrb can overcome the strict requirement for Nanog expression
during reprogramming (Silva et al., 2009). However, whereas
Esrrb induces reprogramming of EpiSCs with greater efficiency
than Nanog in wild-type cells, the opposite is true in EpiSCs
lacking Nanog. The functional overlap between Nanog and
Esrrb is not restricted to the conversion between two distinct
pluripotent states, since Esrrb can substitute for Nanog during
NSC reprogramming by cell fusion. NSCs genetically null for488 Cell Stem Cell 11, 477–490, October 5, 2012 ª2012 Elsevier Inc.Nanog display a lower reprogramming efficiency than wild-
type cells in response to Esrrb. Thus, Esrrb and Nanog act coop-
eratively to induce pluripotency in differentiated cells.
Nanog is required for the formation of the pluripotent epiblast
during preimplantation development. A role for Nanog in
promoting transition to pluripotency has been also shown
in vitro in reprogramming experiments (Silva et al., 2009). The
inability of Nanog/ cells to complete transcription-factor-
based reprogramming mirrors the phenotype observed in
Nanog null embryos, providing a model to study the unique
role of Nanog during the acquisition of pluripotency in early
development. Here we confirm that Nanog is indeed required
for completion of reprogramming but, strikingly, its activity is
not unique. Esrrb can also rescue stalled Nanog/ pre-iPSCs.
This indicates that future studies should address the possibility
that elevated Esrrb expression might also rescue the develop-
mental defects in Nanog null embryos.
These studies demonstrate that Nanog positively regulates
Esrrb in ESCs. Esrrb is not expressed in EpiSCs (Greber et al.,
2010; Han et al., 2010; Osorno and Chambers, 2011; Osorno
et al., 2012) and Nanog is expressed at lower levels in EpiSCs
compared to ESCs (Han et al., 2010; Osorno and Chambers,
2011). In addition, Esrrb and Nanog show different extinction
kinetics during postimplantation development. Esrrb expression
is shut off between E5.5 and E6.5, whereas Nanog shows a
more gradual downregulation, disappearing at the onset of
somitogenesis (Han et al., 2010; Osorno et al., 2012). This may
suggest that additional factors are required for Esrrb expression
or that the Nanog level required to stimulate Esrrb transcription
has a threshold. Future studies should resolve these issues.
Moreover, because human ESCs resemble EpiSCs in gene
expression (Tesar et al., 2007), it will be of interest to determine
the effects of Esrrb expression in human ESCs, particularly as it
relates to attempts to establish human ESCs in a ‘‘ground
state’’(Hanna et al., 2010).
Our results reveal a high degree of mutual dependence
between Nanog and Esrrb function in ESCs. The ability of Nanog
to enhance ESC self-renewal when overexpressed is dependent
on Esrrb expression. Conversely, in all our experiments we
observed reduced effects of Esrrb overexpression in aNanog/
background. Nanog and Esrrb proteins interact (Wang et al.,
2006) and there is overlap between Esrrb and Nanog targets in
ESCs. It will be interesting to see whether some pluripotency
GRN targets are sensitive to the combined loss of Nanog and
Esrrb.
Finally, our results considerably strengthen the available
evidence for the importance of Esrrb in the maintenance of
ESC pluripotency. The consequences of Esrrb loss-of-function
in ESCs has until now been limited to knockdown experiments
(Ivanova et al., 2006). Here we show that Esrrb deletion in
ESCs leads to a severely impaired self-renewal ability, reminis-
cent of the effect of deletion of Nanog (Chambers et al., 2007).
Nonetheless, both Esrrb/ andNanog/ ESCs can be derived.
This is in striking contrast to the absolute requirement for Oct4
and Sox2 in pluripotent cells (Avilion et al., 2003; Masui et al.,
2007; Nichols et al., 1998; Niwa et al., 2000). Combined with
the transcriptional differences in response to Nanog (this study)
or Oct4 (Hall et al., 2009) manipulation, this suggests that some
pluripotency factors like Oct4 lie at the heart of the housekeeping
Cell Stem Cell
Esrrb Functions Downstream of Nanog in ESCsfunctions performed by the transcriptional machinery that
sustains pluripotency in ESCs, while other factors, such as
Nanog, and possibly Esrrb, precisely tune the expression of
a limited number of genes that set the conditions for cell fate
decisions.
EXPERIMENTAL PROCEDURES
ESC Culture
Cells were cultured in GMEMb-mercaptoethanol/10%FCS/LIF as described
(Smith, 1991) or in N2B27 (Ying et al., 2008) supplemented where indicated
with PD0325901 (1 mM) and CHIR99021 (3 mM). Colony-forming assays were
as described (Chambers et al., 2003).
Derivation of EpiSCs from ESCs
EpiSCs were derived as described (Guo et al., 2009). EpiSCs were passaged
every 5–6 days by incubation with 13 accutase (Sigma, Catalogue no: A 6964)
for 5 min, triturated into small clumps of 10–100 cells, neutralized with EpiSC
medium, and replated at the appropriate dilution.
Doxycycline-Inducible Expression
E14Tg2a or TbC44Cre6 cells were transfected with TetO-TdTomato-2a-HygR-
tk and CAG-rtTA-ires-BSDR. Clones were screened for high, homogeneous
TdTomato expression in doxycycline without continued hygromycin selec-
tion and low levels of TdTomato in the absence of doxycycline. An identified
cell line was used for FlpE-catalyzed RCME.
Episomal Reversion of EpiSCs
EpiSCs expressing the large T antigen (E14/T) were transfected with Polyoma
ori+ plasmids using Lipofectamine 2000 (Invitrogen; 11668-019) with 3 mg of
pPyCAGgfpIP, pPyCAGDsRedIP, pPyCAGNanogIP, or pPyCAGEsrrbIP. The
next day 5 3 104 cells were replated in the presence of puromycin and plates
were stained for AP after 7 days. For further analysis, Epi-iPSC colonies were
picked and expanded in the absence of puromycin selection.
Reversion of Nanog–/– EpiSCs
53 104 EpiDN-iNanog and EpiDN-iEsrrb cells were replated in 9 cm dishes in
GMEMb/FCS/LIF +/ doxycycline and plates were stained for AP after 7 days.
Epi-iPSC colonies were also picked and expanded in the absence of
doxycycline.
ESC 3 NSC Fusions
RCNbH(t) NSCs, derived from the RCNbH(t) ESC line, were propagated in
NSC medium with FGF/EGF (Conti et al., 2005). 4 3 106 ESCs were fused to
4 3 106 NSCs (Silva et al., 2006), plated in ES medium with appropriate
selections (see Supplemental Information), and cultured for 14 or 16 days prior
to colony scoring.
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